Due to lack of clinical data, the clinical impact of i(17q) could not be followed up, but in spite of that the present study gives first hints that i(17q) presence may be an indicator for more aggressive course of CLL disease than just TP53 deletion without i(17q) formation. The gene discussed is TP53; the disease is B-cell chronic lymphocytic leukemia.